Menu Back toSignal-Management-Separating-Needles-From-Haystacks

DIA 2018 Global Annual Meeting

Signal Management: Separating Needles From Haystacks

    Session Chair(s)
      Stephen  Knowles, MD, MRCP

      Stephen Knowles, MD, MRCP

      • Vice President, Drug Safety and Pharmacovigilance
      • Halozyme, United States
    to be determined
    Learning Objective : Understand what are the key elements to set the foundation for an unique signal management process throughout the lifecycle stage of a product. Understand how the main parameters influencing signal management evolve in both settings as a tool for signal management decision making.
      Uwe  Trinks, DrSc, PhD

      Experiences with the EVDAS Requirements

      Uwe Trinks, DrSc, PhD

      • Partner and Director
      • Foresight Group, An IQVIA Company, United States
      Margot  Stam Moraga, MPH, MSc

      From Clinical Trial to Postmarketing Signal Management: A Continuum

      Margot Stam Moraga, MPH, MSc

      • Director, Benefit-Risk Management
      • IQVIA, Switzerland